Polymerase chain reaction (PCR) tests reveal infectiousness of hepatitis C
This article was originally published in Clinica
Polymerase chain reaction tests for hepatitis C RNA can be used to tell whether people who are antibody-positive for the disease are likely to be pass it on, Australian researchers have found. The ability to detect infectiousness could help in counselling those exposed to hepatitis C virus (HCV) about the risk of transmission, report Dr Gregory Dore and colleagues in the August 9 issue of the British Medical Journal (Vol 315; pp 333-337).
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.